Market Tracker

12/19 6:43am ET

Halozyme Therapeutics Inc (NASDAQ:HALO)

9.02
Data as of Dec 18
 +0.37 / +4.28%
Today’s Change
6.88
Today|||52-Week Range
18.18
-39.83%
Year-to-Date

Today’s Trading

Previous close8.65
Today’s open8.84
Day’s range-- - --
Volume1,845,654
Average volume (3 months)1,155,452
Market cap$1.1B
Dividend yield--
Data as of 12/18/2014

Growth & Valuation

Earnings growth (last year)-54.17%
Earnings growth (this year)+11.30%
Earnings growth (next 5 years)--
Revenue growth (last year)+29.47%
P/E ratioNM
Price/Sales30.86
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RLYPRelypsa Inc-0.47-1.46%
RDUSRadius Health Inc+0.59+1.91%
IMGNImmunoGen Inc+0.13+1.17%
OVASOvaScience Inc+8.26+23.63%
Data as of 12/18/2014

Financials

Next reporting dateMarch 13, 2015
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$54.8M
Annual profit (last year)-$83.5M
Net profit margin-152.33%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts